Friday, September 20, 2024 8:10:54 PM
Over the course of the last 34 trading days (Counting Today) we have had 26 GREEN CLOSES and only 8 RED CLOSES. The stock has been remarkably resilient even when presented with temporary opportunities to push it lower. Gauging by these two barometers. One could only reasonable conclude that the market sentiment around RDGL has been, and is becoming, increasingly more bullish with each passing day. Thanks to the gracious information sharing being disseminated by the company’s public relations through X and the Radiogel website investors understand this bullish sentiment is not without merit. I say investors because this company has been blessed with more than just it's fair share of them. I expect them to continue to keep the line of communication open and share pertinent information as it becomes available. These next 4 weeks give us so much to be looking forward to.....https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/historical
Didn't get that UPDATE today like I was expecting.....the missing link to today's and this whole weeks worth of amazing resilience and head strong resistance to all things RED.....
$RDGL Trend Continues Higher High's Higher Low's Higher Close's
Date***********Close**High***Low*******Volume
20 Sept 2024 0.1634 0.1678 0.1575***** 645,738
19 Sept 2024 0.1598 0.1645 0.1510***** 506,525
18 Sept 2024 0.1562 0.1622 0.1505*** 1,125,259
17 Sept 2024 0.1553 0.1583 0.1495***** 865,500
16 Sept 2024 0.1540 0.1574 0.1461***** 951,042
13 Sept 2024 0.1455 0.1545 0.1338*** 1,095,701
12 Sept 2024 0.1355 0.1450 0.1331***** 805,270
11 Sept 2024 0.1420 0.1465 0.1386***** 267,709
10 Sept 2024 0.1414 0.1503 0.1300*** 1,553,373
09 Sept 2024 0.1301 0.1420 0.1230*** 1,317,001
06 Sept 2024 0.1230 0.1270 0.1175***** 553,374
05 Sept 2024 0.1210 0.1259 0.1080*** 1,099,808
04 Sept 2024 0.1186 0.1840 0.1030*** 6,309,957 >>>>News of FDA re-submission delay
03 Sept 2024 0.1516 0.1579 0.1339*** 1,112,67
https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/historical
Didn't get that UPDATE today like I was expecting.....the missing link to today's and this whole weeks worth of amazing resilience and head strong resistance to all things RED.....
$RDGL Trend Continues Higher High's Higher Low's Higher Close's
Date***********Close**High***Low*******Volume
20 Sept 2024 0.1634 0.1678 0.1575***** 645,738
19 Sept 2024 0.1598 0.1645 0.1510***** 506,525
18 Sept 2024 0.1562 0.1622 0.1505*** 1,125,259
17 Sept 2024 0.1553 0.1583 0.1495***** 865,500
16 Sept 2024 0.1540 0.1574 0.1461***** 951,042
13 Sept 2024 0.1455 0.1545 0.1338*** 1,095,701
12 Sept 2024 0.1355 0.1450 0.1331***** 805,270
11 Sept 2024 0.1420 0.1465 0.1386***** 267,709
10 Sept 2024 0.1414 0.1503 0.1300*** 1,553,373
09 Sept 2024 0.1301 0.1420 0.1230*** 1,317,001
06 Sept 2024 0.1230 0.1270 0.1175***** 553,374
05 Sept 2024 0.1210 0.1259 0.1080*** 1,099,808
04 Sept 2024 0.1186 0.1840 0.1030*** 6,309,957 >>>>News of FDA re-submission delay
03 Sept 2024 0.1516 0.1579 0.1339*** 1,112,67
https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/historical
Never buy a stock based on my opinion of that stock.Form your own opinion by doing your own DD.My position on any stock I buy can change without notice.I am not a licensed broker or stock adviser and I really don't know what I'm doing.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
